Rick Bright, who had served as the director of the Biomedical Advanced Research and Development Authority until the end of last month, disagreed ...
News
- Departed health official says he clashed with bosses on virus
- Chegg, Tenet rise; Norwegian Cruise Line, WestRock fall
The biotechnology company is being bought by Alexion Pharmaceuticals for just over $1.4 billion. Norwegian Cruise Line Holdings Ltd., down $3.26 ...
- Whistleblower: US failed to prepare, sought quick virus fix
Dr. Rick Bright, former director of the Biomedical Advanced Research and Development Authority, alleges he was reassigned to a lesser role because ...
- Cerus: 1Q Earnings Snapshot
The biomedical products company posted revenue of $18.6 million in the period. Cerus expects full-year revenue in the range of $89 million to $93 ...
- UT Health San Antonio researchers study antibodies against coronavirus
UT Health San Antonio researchers are working with colleagues at the Texas Biomedical Research Institute, where biosafety level 3 and 4 labs ...